Sep. 4 at 5:33 PM
$ADAPY but we wouldn't have to be the one's splitting to get over 4. It would be the company currently listed on the nasdaq that splits, does a name change and we are the acquirors. I was holding AGBA a nasdaq company and they were bought out by
$ILLR which was private but went public via reverse merger. There are benefits to delisting to the otc as it is cheaper and it gives them time to regroup without having to reverse split just to stay on nasdaq. There may be nasdaq companies that know they have to reverse split regardless so a reverse merger is a consideration for them and they get acquired. The main asset we have is cash to fund another biotechs drug development and if it's in the cancer space sobeit even better. OTC companies are looked upon as being private because of their lack of a need for reporting so they could go public via reverse merger
